IMNM

Immunome Inc.

$23.61 +2.12 (+9.87%) At close · Jul 2

Market Cap

$2.67B

113,250,394

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Clay Siegall	CEO	$162,500	—	—	$14,215,856	$483,600	$4,875	$14,866,831
Bob Lechleider	—	$101,042	$50,000	—	$2,706,000	$58,320	—	$2,915,362
Jack Higgins	—	$107,916	$250,000	—	$1,212,900	$266,800	$3,238	$1,840,854
Purnanand D. Sarma	CEO	$440,820	$210,600	—	$38,242	—	$741,238	$1,437,295

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Purnanand D. Sarma	CEO	$540,000	—	—	$221,333	$216,000	$12,976	$990,309

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dennis H. Giesing	—	$306,971	$50,000	—	$3,055,236	$84,318	$3,392	$3,499,917
Corleen M. Roche	CFO	$282,051	$50,000	—	$2,670,236	$89,775	$4,281	$3,096,344
Purnanand D. Sarma	CEO	$540,000	—	—	$1,371,370	$189,000	$12,478	$2,111,914

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Purnanand D. Sarma	CEO	$435,000	—	—	$1,037,560	$211,561	$10,881	$1,695,002
Sandra Stoneman	General Counsel	$71,571	$15,000	—	$1,196,828	$30,632	$366	$1,314,397
Michael J. Morin	—	$249,385	—	—	$559,694	$108,204	$19,523	$936,806

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael J. Morin	—	$220,000	—	—	—	$110,000	$33,770	$363,770
Purnanand D. Sarma	CEO	$233,333	—	—	—	$81,666	$24,911	$339,910
Sandra Stoneman	General Counsel	—	—	—	—	—	—	—

Key facts CIK 1472012 CUSIP 45257U108 13F (30d) 2 filings 1 filers Visit website Investor relations